tru Independence LLC lowered its stake in Enovix Co. (NASDAQ:ENVX – Free Report) by 5.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 285,210 shares of the company’s stock after selling 15,025 shares during the quarter. tru Independence LLC owned 0.16% of Enovix worth $3,100,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of the stock. Prospera Private Wealth LLC bought a new stake in Enovix during the 3rd quarter valued at $27,000. Fifth Third Bancorp increased its position in shares of Enovix by 66.7% during the fourth quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock worth $27,000 after acquiring an additional 1,000 shares in the last quarter. Strategic Investment Solutions Inc. IL bought a new stake in shares of Enovix during the second quarter worth about $39,000. Voisard Asset Management Group Inc. increased its position in shares of Enovix by 40.0% during the third quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company’s stock worth $65,000 after acquiring an additional 2,000 shares in the last quarter. Finally, Quest Partners LLC increased its holdings in Enovix by 318.5% during the 3rd quarter. Quest Partners LLC now owns 8,270 shares of the company’s stock worth $77,000 after purchasing an additional 6,294 shares in the last quarter. Institutional investors own 50.92% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have commented on ENVX. JPMorgan Chase & Co. decreased their price objective on Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $30.00 target price on shares of Enovix in a research note on Wednesday, October 30th. Janney Montgomery Scott lowered shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target on the stock. in a research report on Thursday, October 31st. Finally, Benchmark reaffirmed a “buy” rating and issued a $25.00 price objective on shares of Enovix in a research report on Wednesday, October 30th. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $20.50.
Enovix Stock Down 7.0 %
Shares of NASDAQ ENVX opened at $11.45 on Monday. Enovix Co. has a 52 week low of $5.70 and a 52 week high of $18.68. The business has a 50-day simple moving average of $10.30 and a two-hundred day simple moving average of $10.77. The company has a quick ratio of 3.61, a current ratio of 3.77 and a debt-to-equity ratio of 0.99. The company has a market cap of $2.04 billion, a P/E ratio of -7.30 and a beta of 1.86.
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.03. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. The company had revenue of $4.30 million during the quarter, compared to analyst estimates of $4.11 million. During the same period last year, the business earned ($0.27) earnings per share. Research analysts anticipate that Enovix Co. will post -1.17 earnings per share for the current fiscal year.
Insider Buying and Selling at Enovix
In other news, Director Betsy S. Atkins sold 75,000 shares of Enovix stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the completion of the sale, the director now owns 99,497 shares in the company, valued at approximately $968,105.81. This trade represents a 42.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 15.70% of the company’s stock.
Enovix Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Articles
- Five stocks we like better than Enovix
- Health Care Stocks Explained: Why You Might Want to Invest
- The 3 Biggest M&A Stock Opportunities for 2025
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- A Pivotal Moment for the Consumer Discretionary Sector
- Trading Halts Explained
- How Mixed Analyst Opinions Are Shaping Apple Stock’s Outlook
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.